Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
Showing 38,001 - 38,020 results of 101,459 for search '(( 5 point decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 38001
    Artificial enhancer constructs reveal a tandem-<i>like</i> structure.

    Artificial enhancer constructs reveal a tandem-<i>like</i> structure. by Maximilian Haeussler (86348)

    Published 2010
    “…The element has been divided into five parts (a, b, c, d, e). (ab) fragment is in dark blue, (d) in light blue with blue outline, (e) in light blue. …”
    Save to List
    Saved in:
  2. 38002
    Image1_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG

    Image1_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG by Panayiota Christodoulou (13832038)

    Published 2022
    “…As attested by flow cytometry, combination treatment was associated with decreased the percentage of late apoptotic cells compared with monotherapy (fold-change of decrease = 1.6 and 4.5 for 15 and 20 μΜ, respectively). …”
    Save to List
    Saved in:
  3. 38003
    A Preorganized Ditopic Borane as Highly Efficient One- or Two-Electron Trap

    A Preorganized Ditopic Borane as Highly Efficient One- or Two-Electron Trap by Alexander Hübner (1635205)

    Published 2015
    “…EPR spectroscopy on Li­[<b>1</b>] reveals hyperfine coupling of the unpaired electron to two magnetically equivalent boron nuclei (<i>a</i>(<sup>11</sup>B) = 5.1 ± 0.1 G, <i>a</i>(<sup>10</sup>B) = 1.7 ± 0.2 G). …”
    Save to List
    Saved in:
  4. 38004
    Image2_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG

    Image2_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG by Panayiota Christodoulou (13832038)

    Published 2022
    “…As attested by flow cytometry, combination treatment was associated with decreased the percentage of late apoptotic cells compared with monotherapy (fold-change of decrease = 1.6 and 4.5 for 15 and 20 μΜ, respectively). …”
    Save to List
    Saved in:
  5. 38005
    Polyamine depletion reroutes energy production to glycolysis.

    Polyamine depletion reroutes energy production to glycolysis. by Yazmin E. Cruz-Pulido (20285238)

    Published 2024
    Save to List
    Saved in:
  6. 38006
    Identification of Yhp1/Yox1-regulated genes.

    Identification of Yhp1/Yox1-regulated genes. by Michelle M. Conti (13514386)

    Published 2022
    Save to List
    Saved in:
  7. 38007
    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis

    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis by Amber Kunkel (3208332)

    Published 2016
    “…</p><p>Methods and Findings</p><p>We created a Markov decision model to follow a hypothetical cohort of multidrug-resistant (MDR) TB patients under different bedaquiline use strategies. …”
    Save to List
    Saved in:
  8. 38008
    Citation patterns of Cochrane Reviews and other systematic reviews: a bibliometric analysis

    Citation patterns of Cochrane Reviews and other systematic reviews: a bibliometric analysis by Louise Olsbro Rosengaard (20439098)

    Published 2025
    “…</p> <p>We conducted a bibliometric analysis of systematic reviews indexed in PubMed from 1993 to 2022. …”
    Save to List
    Saved in:
  9. 38009
    Community growth.

    Community growth. by Alessia Iancarelli (12441835)

    Published 2022
    “…We suspect that this trend might be due to a delay in the uploading of papers in the semantic scholar database and it should not have to reflect a real significant decrease of the interest in the field.…”
    Save to List
    Saved in:
  10. 38010
    Data_Sheet_8_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF

    Data_Sheet_8_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  11. 38011
    Data_Sheet_4_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF

    Data_Sheet_4_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  12. 38012
    Table_10_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_10_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  13. 38013
    Table_2_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_2_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  14. 38014
    Table_11_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_11_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  15. 38015
    Table_12_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_12_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  16. 38016
    Table_8_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_8_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  17. 38017
    Table_1_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.DOCX

    Table_1_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.DOCX by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  18. 38018
    Table_3_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS

    Table_3_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.XLS by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  19. 38019
    Data_Sheet_9_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF

    Data_Sheet_9_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:
  20. 38020
    Data_Sheet_1_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF

    Data_Sheet_1_Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.PDF by Shun Li (330132)

    Published 2021
    “…Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. …”
    Save to List
    Saved in:

Search Tools: